BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
22 results:

  • 1. Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis.
    Li Y; Wang Z; Lu F; Miao Y; Feng Q; Zhu W; Kang Q; Chen Y; Zhang Q
    Sci Rep; 2024 Apr; 14(1):8375. PubMed ID: 38600248
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FABP6 serves as a new therapeutic target in esophageal tumor.
    Zhang D; Zhao F; Liu H; Guo P; Li Z; Li S
    Aging (Albany NY); 2024 Jan; 16(2):1640-1662. PubMed ID: 38277205
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model.
    Li CX; He Q; Wang ZY; Fang C; Gong ZC; Zhao HR; Ling B
    Head Neck; 2023 Oct; 45(10):2515-2524. PubMed ID: 37548087
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.
    An PG; Wu WJ; Tang YF; Zhang J
    Funct Integr Genomics; 2023 May; 23(2):155. PubMed ID: 37162576
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical features and factors affecting prognosis and partial deterioration of ocular papilloma: a retrospective study of 298 cases.
    Jian H; He W
    Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2395-2402. PubMed ID: 36933010
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
    Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
    Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
    Wang Z; Luo J; Zhang Y; Xun P; Chen Z
    PLoS One; 2022; 17(7):e0271038. PubMed ID: 35901016
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
    Christianto S; Li KY; Huang TH; Su YX
    Laryngoscope; 2022 Sep; 132(9):1760-1770. PubMed ID: 34953144
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
    Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
    J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.
    Zheng YZ; Li XQ; Wang JY; Yang H; Wen J; Zhai WY; Yuan LX; Fu SS; Liao HY; Fu JH
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1956-1962. PubMed ID: 32439262
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is biopsy enough for papillary thyroid microcarcinoma?: An analysis of the SEER database 2004 to 2013 with propensity score matching.
    Liu Z; Zhao Q; Liu C; Zeng W; Ming J; Chen C; Wang S; Xiong Y; Zhang C; Chen T; Huang T; Guo L
    Medicine (Baltimore); 2018 Aug; 97(31):e11791. PubMed ID: 30075609
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
    Hanemaaijer SH; van Gijn SE; Oosting SF; Plaat BEC; Moek KL; Schuuring EM; van der Laan BFAM; Roodenburg JLN; van Vugt MATM; van der Vegt B; Fehrmann RSN
    Oral Oncol; 2018 May; 80():33-39. PubMed ID: 29706186
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.
    Li SH; Lu HI; Huang WT; Tien WY; Lan YC; Lin WC; Tsai HT; Chen CH
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351209
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
    Lechien JR; Nassri A; Kindt N; Brown DN; Journe F; Saussez S
    Head Neck; 2017 Dec; 39(12):2573-2584. PubMed ID: 28963807
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic significance of PTK7 in human malignancies.
    Chen G; Qi S; Yang X; Chen W
    Histol Histopathol; 2018 Apr; 33(4):379-388. PubMed ID: 28924970
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic efficacy of combining tumor volume with Epstein-Barr virus DNA in patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Lu L; Li J; Zhao C; Xue W; Han F; Tao T; Chang H; Jia W; Lu T
    Oral Oncol; 2016 Sep; 60():18-24. PubMed ID: 27531868
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predicting the prognosis of Oral Tongue Carcinoma Using a Simple Quantitative Measurement Based on Preoperative MR Imaging: Tumor Thickness versus Tumor Volume.
    Hu H; Cheng KL; Xu XQ; Wu FY; Tyan YS; Tsai CH; Shen CY
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1338-42. PubMed ID: 25836729
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.
    Rades D; Seibold ND; Gebhard MP; Noack F; Bruchhage KL; Schild SE
    Strahlenther Onkol; 2014 Jan; 190(1):68-74. PubMed ID: 23861152
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [MIF in head and neck cancer: a new therapeutic target ?].
    Lechien JR; Kindt N; Costa Pde A; Chantrain G; Preillon J; Laurent G; Saussez S
    Rev Laryngol Otol Rhinol (Bord); 2013; 134(2):67-74. PubMed ID: 24683815
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.